Concepedia

Steven W. Andrews

SW

Statistics

Publications

29

Citations

2K

H-Index

21

Active since

1986

Affiliations

Array BioPharma (United States)(Current)

Loxo Oncology at Lilly (United States)

Allergan (United States)

University of Colorado Boulder

Japan Tobacco (Japan)

Steven W. Andrews is an author at Array BioPharma (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1986–2021

29

Publications

29

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

Aria Vaishnavi, Marzia Capelletti, Anh T. Le et al. · Nature Medicine · 2013 · 582 citations · Full text

, , +3

Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)

Scott D. Seiwert, Steven W. Andrews, Yutong Jiang et al. · Antimicrobial Agents and Chemotherapy · 2008 · 173 citations · Full text

, , +14

Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024)

David F. Woodward, Achim H.‐P. Krauss, J. Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 146 citations

Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease

Yutong Jiang, Steven W. Andrews, Kevin R. Condroski et al. · Journal of Medicinal Chemistry · 2013 · 139 citations · Full text

, , +17

Colonization of the Human Oral Cavity by a Streptococcus mutans Mutant Producing Increased Bacteriocin

J.D. Hillman, A.L. Dzuback, Steven W. Andrews · Journal of Dental Research · 1987 · 103 citations

1–5 of 29